Cargando…
SKLB023 protects mice against acute liver injury by inhibiting proinflammatory cytokine production in both T cells and macrophages
Acute liver failure is a severe clinical syndrome accompanied with excessive inflammatory response. Our previous study demonstrated that SKLB023, a novel thiazolidinedione derivative, showed potent anti-inflammatory activity in rheumatoid arthritis. The purpose of the present study is to evaluate th...
Autores principales: | Yu, Jia, Liu, Lili, Zhang, Huiming, Wu, Yating, Pei, Heying, Ma, Liang, Xiong, Anwen, Xie, Caifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086442/ https://www.ncbi.nlm.nih.gov/pubmed/35548127 http://dx.doi.org/10.1039/c8ra03720e |
Ejemplares similares
-
SKLB023 Blocks Joint Inflammation and Cartilage Destruction in Arthritis Models via Suppression of Nuclear Factor-Kappa B Activation in Macrophage
por: Xie, Caifeng, et al.
Publicado: (2013) -
Protective effects of SKLB023 on a mouse model of unilateral ureteral obstruction by the modulation of gut microbiota
por: Feng, Yanhuan, et al.
Publicado: (2018) -
SKLB023 as an iNOS inhibitor alleviated liver fibrosis by inhibiting the TGF-beta/Smad signaling pathway
por: Zhang, Jinhang, et al.
Publicado: (2018) -
SKLB023 hinders renal interstitial fibrosis in obstructive nephropathy by interfering TGF-β1/Smad3 signaling
por: Feng, Yanhuan, et al.
Publicado: (2018) -
Mixed micelles loaded with the 5-benzylidenethiazolidine-2,4-dione derivative SKLB023 for efficient treatment of non-alcoholic steatohepatitis
por: Li, Yanping, et al.
Publicado: (2019)